Brinton Pharma gets DCGI nod to market Favipiravir for treatment of COVID-19 patients

Brinton Pharma gets DCGI nod to market Favipiravir for treatment of COVID-19 patients
Brinton Pharma gets DCGI nod to market Favipiravir for treatment of COVID-19 patients To be available in 200 mg tablets, the drug will be sold at a maximum retail price of Rs 59 per tablet, Brinton Pharmaceuticals said in a statement.